Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 213

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort

Open access
Shinjo, Samuel K., Bonfá, Eloísa, Wojdyla, Daniel, Borba, Eduardo F., Ramirez, Luis A., Scherbarth, Hugo R., Brenol, João C. Tavares, Chacón‐Diaz, Rosa, Neira, Oscar J., Berbotto, Guillermo A., de la Torre, Ignacio Garcia, Acevedo‐Vázquez, Eduardo M., Massardo, Loreto, Barile‐Fabris, Leonor A., Caeiro, Francisco, Silveira, Luis H., Sato, Emilia I., Buliubasich, Sandra, Alarcón, Graciela S., Pons‐Estel, Bernardo A. · 2010 · Arthritis & Rheumatism

Abstract

Objective: To evaluate the beneficial effect of antimalarial treatment on lupus survival in a large, multiethnic, international longitudinal inception cohort. Methods: Socioeconomic and demographic characteristics, clinical manifestations, classification criteria, laboratory findings, and treatment variables were examined in patients with systemic lupus erythematosus (SLE) from the Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL) cohort. The diagnosis of SLE, according to the American College of Rheumatology criteria, was assessed within 2 years of cohort entry. Cause of death was classified as active disease, infection, cardiovascular complications, thrombosis, malignancy, or other cause. Patients were subdivided by antimalarial use, grouped according to those who had received antimalarial drugs for at least 6 consecutive months (user) and those who had received antimalarial drugs for <6 consecutive months or who had never received antimalarial drugs (nonuser). Results: Of the 1,480 patients included in the GLADEL cohort, 1,141 (77%) were considered antimalarial users, with a mean duration of drug exposure of 48.5 months (range 6–98 months). Death occurred in 89 patients (6.0%). A lower mortality rate was observed in antimalarial users compared with nonusers (4.4% versus 11.5%; P< 0.001). Seventy patients (6.1%) had received antimalarial drugs for 6–11 months, 146 (12.8%) for 1–2 years, and 925 (81.1%) for >2 years. Mortality rates among users by duration of antimalarial treatment (per 1,000 person‐months of followup) were 3.85 (95% confidence interval [95% CI] 1.41–8.37), 2.7 (95% CI 1.41–4.76), and 0.54 (95% CI 0.37–0.77), respectively, while for nonusers, the mortality rate was 3.07 (95% CI 2.18–4.20) (P for trend < 0.001). After adjustment for potential confounders in a Cox regression model, antimalarial use was associated with a 38% reduction in the mortality rate (hazard ratio 0.62, 95% CI 0.39–0.99). Conclusion: Antimalarial drugs were shown to have a protective effect, possibly in a time‐dependent manner, on SLE survival. These results suggest that the use of antimalarial treatment should be recommended for patients with lupus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.27300

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 213

Metadata

Authors
Shinjo, S. K., Bonfá, E., Wojdyla, D., Borba, E. F., Ramirez, L. A., Scherbarth, H. R., Brenol, J. C. T., Chacón‐Diaz, R., Neira, O. J., Berbotto, G. A., de la Torre, I. G., Acevedo‐Vázquez, E. M., Massardo, L., Barile‐Fabris, L. A., Caeiro, F., Silveira, L. H., Sato, E. I., Buliubasich, S., Alarcón, G. S., & Pons‐Estel, B. A.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2010-02-25
Volume
62
Issue
3
Pages
855-862
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2088887888
Cited by
213
References
3
FWCI
9.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort. https://app.cochat.ai/papers/10.1002/art.27300
The paper
Shinjo, S. K., Bonfá, E., Wojdyla, D., Borba, E. F., Ramirez, L. A., Scherbarth, H. R., Brenol, J. C. T., Chacón‐Diaz, R., Neira, O. J., Berbotto, G. A., de la Torre, I. G., Acevedo‐Vázquez, E. M., Massardo, L., Barile‐Fabris, L. A., Caeiro, F., Silveira, L. H., Sato, E. I., Buliubasich, S., Alarcón, G. S., & Pons‐Estel, B. A. (2010). Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort. Arthritis & Rheumatism. https://doi.org/10.1002/art.27300

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.